A novel variant of interest of SARS-CoV-2 with multiple spike mutations is identified from travel surveillance in Africa
de Oliveira, T.; Lutucuta, S.; Nkengasong, J.; Morais, J.; Paula Paixao, J.; Neto, Z.; Afonso, P.; Miranda, J.; David, K.; Ingles, L.; Carralero, A. P. A. P. R. R.; Freitas, H. R.; Mufinda, F.; Tessema, S. K.; Tegally, H.; San, E. J.; Wilkinson, E.; Giandhari, J.; Pillay, S.; Giovanetti, M.; Naidoo, Y.; Singh, L.; Tshiabuila, D.; Martin, D.; Lessells, R. J.
Show abstract
At the end of 2020, the Network for Genomic Surveillance in South Africa (NGS-SA) detected a SARS-CoV-2 variant of concern (VOC) in South Africa (501Y.V2 or PANGO lineage B.1.351)1. 501Y.V2 is associated with increased transmissibility and resistance to neutralizing antibodies elicited by natural infection and vaccination2,3. 501Y.V2 has since spread to over 50 countries around the world and has contributed to a significant resurgence of the epidemic in southern Africa. In order to rapidly characterize the spread of this and other emerging VOCs and variants of interest (VOIs), NGS-SA partnered with the Africa Centres for Disease Control and Prevention and the African Society of Laboratory Medicine through the Africa Pathogen Genomics Initiative to strengthen SARS-CoV-2 genomic surveillance across the region.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.